Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism

Cancer Research

Volumn 63, Issue 11, 2003, Pages 2997-3000

  Hembrough, Todd A ^a   Swartz, Glenn M ^a   Papathanassiu, Adonia ^a   Vlasuk, George P ^b   Rote, William E ^b   Green, Shawn J ^a   Pribluda, Victor S ^a  

^a ENTREMED INC   (United States)

^b Dendreon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT PROTEIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; PROTEIN RNAPC2; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CLOTTING; CANCER GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; GROWTH INHIBITION; HEMOSTASIS; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOSIS; TUMOR GROWTH;

ANIMALS; ANTICOAGULANTS; CELL DIVISION; FACTOR VIIA; HELMINTH PROTEINS; LIPOPROTEINS; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; THROMBOPLASTIN;

EID: 0037567437     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hoffman, R., Haim, N., and Brenner, B. Cancer and thrombosis revisited. Blood Rev., 15: 61-67, 2001.
2. Rickles, F. R., and Falanga, A. Molecular basis for the relationship between thrombosis and cancer. Thromb. Res., 102: V215-V224, 2001.
3. Palumbo, J. S., Kombrinck, K. W., Drew, A. F., Grimes, T. S., Kiser, J. H., Degen, J. L., and Bugge, T. H. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood, 96: 3302-3309, 2000.
4. Donnelly, K. M., Bromberg, M. E., Milstone, A., Madison McNiff, J. M., Terwilliger, G., Konigsberg, W. H., and Cappello. M. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro. Thromb. Haemost., 79: 1041-1047, 1998.
5. Esumi, N., Fan, D., and Fidler, I. J. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res., 51: 4549-4556, 1991.
6. Hejna, M., Raderer, M., and Zielinski, C. C. Inhibition of metastases by anticoagulants. J. Natl. Cancer Inst. (Bethesda). 91: 22-36, 1999.
7. Cosgrove. R. H., Zacharski, L. R., Racine, E., and Andersen, J. C. Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence. Semin. Thromb. Hemost., 28: 79-87, 2002.
8. Zacharski, L. R., Henderson, W. G., Rickles, F. R., Forman, W. B., Cornell, C. J., Jr., Forcier, R. J., Edwards, R. L., Headley, E., Kim, S. H., and O'Donnell, J. F. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer, 53: 2046-2052, 1984.
9. Lebeau, B., Chastang, C., Brechot, J. M., Capron, F., Dautzenberg, B., Delaisements, C. Mornet, M., Brun, J., Hurdebourcq, J. P., and Lemarie, E. Subcutaneous heparin treatment increase survival in small cell lung cancer. "Petites Cellules," Group Cancer. 74: 38-45, 1994.
10. Schulman, S., and Lindmarker, P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N. Engl. J. Med., 342: 1953-1958, 2000.
11. Ornstein. D. L., and Zacharski, L. R. Activity of heparins in experimental models of malignancy: possible explanations for anticancer effects in humans, Clin. Hemorheol. Microcirc., 26: 33-40, 2002.
12. Berkner, K. L. The vitamin K-dependent carboxylase. J. Nutr., 130: 1877-1880, 2000.
13. Fernandez, P., and Rickles, F. R. Tissue factor and angiogenesis in cancer. Curr. Opin. Hematology, 9: 401-406, 2002.
14. Ruf, W., Fischer, E. G., Huang, H. Y., Miyagi, Y., Ott, I., Riewald, M., and Mueller, B. M. Diverse functions of protease receptor tissue factor in inflammation and metastasis. Immunol. Res., 21: 289-292, 2000.
15. Belaaouaj, A. A., Li, A., Wun, T. C., Welgus, H. G., and Shapiro, S. D. Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J. Biol. Chem., 275: 27123-27128, 2000.
16. Bergum, P. W., Cruikshank, A., Maki, S. L., Kelly, C. R., Ruf, W., and Vlasuk, G. P. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2. J. Biol. Chem., 276: 10063-10071, 2001.
17. Cappello, M., Vlasuk, G. P., Bergum, P. W., Huang, S., and Hotez, P. J. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc. Natl. Acad. Sci. USA. 92: 6152-6156, 1995.
18. Hembrough, T. A., Ruiz, J. F., Papathanassiu, A. E., Green, S. J., and Strickland, D. K. Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor. J. Biol. Chem., 276: 12241-12248, 2001.
19. Tuszynski, G. P., Gasic, T. B., and Gasic, G. J. Isolation and characterization of antistasin. An inhibitor of metastasis and coagulation. J. Biol. Chem., 262: 9718-9723, 1987.
20. Coughlin, S. R. Protease-activated receptors in vascular biology. Thromb. Haemost., 86: 298-307, 2001.
21. Riewald, M., and Ruf, W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc. Natl. Acad. Sci. USA, 98: 7742-7747, 2001.
22. Camerer, E., Huang, W., and Coughlin, S. R. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. USA, 97: 5255-5260, 2000.
23. Lee, A., Agnelli, G., Buller, H., Ginsberg, J., Heit, J., Rote, W., Vlasuk, G., Costantini, L., Julian, J., Comp, P., van Der Meer, J., Piovella, F., Raskob, G., and Gent, M. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation, 104: 74-78, 2001.